Testing effectiveness (Phase 2)Study completedNCT00017329What this trial is testingPS-341 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00032188What this trial is testingInterleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Study completedNCT00002473What this trial is testingKidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC
Not applicableUnknownNCT03226886What this trial is testingTRACERx Renal CAPTURE Sub-studyWho this might be right forRenal Cell CarcinomaCancerHealthy Volunteers Royal Marsden NHS Foundation Trust 360
Not applicableStudy completedNCT00073879What this trial is testingFludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationWho this might be right forKidney Cancer Baylor College of Medicine
Not applicableUnknownNCT06391879What this trial is testingEstablishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell CarcinomaWho this might be right forVHL SyndromeRenal Cell Carcinoma Peking University First Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01798446What this trial is testingA Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusWho this might be right forRenal Cell CarcinomaNonclear CellTemsirolimus Resistance Seoul National University Hospital 41
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Early research (Phase 1)Looking for participantsNCT07187869What this trial is testingModulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept StudyWho this might be right forClear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00003551What this trial is testingAminocamptothecin in Treating Patients With Advanced or Recurrent Kidney CancerWho this might be right forKidney Cancer Emory University
Not applicableNo Longer AvailableNCT06090331What this trial is testing89Zr-DFO-girentuximab Expanded Access Program (EAP)Who this might be right forClear Cell Renal Cell Carcinoma Telix Pharmaceuticals (Innovations) Pty Limited
Testing effectiveness (Phase 2)WithdrawnNCT02763761What this trial is testingAn Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWho this might be right forRenal Cell CarcinomaMelanomaLung Cancer Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT02386826What this trial is testingINC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma MultiformeGliosarcomaColorectal Cancer+1 more SCRI Development Innovations, LLC 65
Large-scale testing (Phase 3)Study completedNCT00111020What this trial is testingTreatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Bayer 2,567
Testing effectiveness (Phase 2)UnknownNCT05879497What this trial is testing68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma SuspicionWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03875313What this trial is testingStudy of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid TumorsWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more Calithera Biosciences, Inc 33
Not applicableUnknownNCT04666220What this trial is testingVETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal CarcinomaWho this might be right forRenal Cell CarcinomaAdrenal Carcinoma Humanitas Clinical and Research Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546What this trial is testingNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell CancerWho this might be right forRenal Cell Carcinoma The Netherlands Cancer Institute 69
Not applicableStudy completedNCT05070637What this trial is testingCirculating Tumor Cell Reducing No-touch NephrectomyWho this might be right forRenal Cell CarcinomaCirculating Tumor Cell Hospital de Santa Maria, Portugal 44
Testing effectiveness (Phase 2)UnknownNCT04631731What this trial is testingRisk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityWho this might be right forLung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more Western Sydney Local Health District 200